Cargando…
Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
OBJECTIVE: To evaluate the clinical efficacy and safety of a short course of blinatumomab in children with refractory or relapsed precursor B-cell acute lymphoblastic leukemia (R/R-BCP-ALL). METHODS: The clinical data of 33 R/R BCP-ALL children aged 0–18 years who underwent a short course of blinatu...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437063/ https://www.ncbi.nlm.nih.gov/pubmed/37601130 http://dx.doi.org/10.3389/fped.2023.1187607 |